We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$3.48B
AUM Growth
+$211M
Cap. Flow
+$149M
Cap. Flow %
4.28%
Top 10 Hldgs %
63.27%
Holding
329
New
32
Increased
177
Reduced
75
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 4.12%
2 Financials 2.19%
3 Communication Services 1.35%
4 Healthcare 0.61%
5 Consumer Discretionary 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGK icon
151
Vanguard Mega Cap Growth ETF
MGK
$31.8B
$1.19M 0.03%
14,410
+10,840
+304% +$890K
AOA icon
152
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.16B
$1.18M 0.03%
13,227
+409
+3% +$36.4K
MMM icon
153
3M
MMM
$94.1B
$1.15M 0.03%
7,188
+173
+2% +$28.3K
TT icon
154
Trane Technologies
TT
$104B
$1.14M 0.03%
2,933
-629
-18% -$260K
GLD icon
155
SPDR Gold Trust
GLD
$131B
$1.07M 0.03%
2,693
+44
+2% +$16.8K
DHR icon
156
Danaher
DHR
$140B
$1.03M 0.03%
4,495
+366
+9% +$80.5K
UNH icon
157
UnitedHealth
UNH
$389B
$999K 0.03%
3,026
-50
-2% -$16.9K
SPG icon
158
Simon Property Group
SPG
$76.8B
$996K 0.03%
5,380
+91
+2% +$16.5K
MPC icon
159
Marathon Petroleum
MPC
$89.3B
$977K 0.03%
6,007
-622
-9% -$116K
LLY icon
160
Eli Lilly
LLY
$1.09T
$969K 0.03%
902
+335
+59% +$320K
BN icon
161
Brookfield
BN
$104B
$957K 0.03%
+20,846
New +$951K
KO icon
162
Coca-Cola
KO
$380B
$955K 0.03%
13,659
+939
+7% +$65.5K
USB icon
163
US Bancorp
USB
$100B
$943K 0.03%
17,681
-157
-0.9% -$7.72K
SLGN icon
164
Silgan Holdings
SLGN
$5.07B
$935K 0.03%
23,153
+25
+0.1% +$1.01K
VGSH icon
165
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$930K 0.03%
15,830
-98
-0.6% -$5.76K
IVE icon
166
iShares S&P 500 Value ETF
IVE
$49.6B
$918K 0.03%
4,327
+103
+2% +$21.6K
QSR icon
167
Restaurant Brands International
QSR
$26B
$893K 0.03%
13,091
+19
+0.1% +$1.31K
DVY icon
168
iShares Select Dividend ETF
DVY
$24.1B
$882K 0.03%
6,251
GS icon
169
Goldman Sachs
GS
$305B
$877K 0.03%
998
+122
+14% +$99.5K
AMAT icon
170
Applied Materials
AMAT
$378B
$836K 0.02%
3,252
+247
+8% +$59.2K
TMO icon
171
Thermo Fisher Scientific
TMO
$214B
$817K 0.02%
1,410
-207
-13% -$117K
QEMM icon
172
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$53.3M
$800K 0.02%
12,092
IJT icon
173
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.27B
$798K 0.02%
5,653
+752
+15% +$106K
HDV
174
iShares Core High Dividend ETF
HDV
$14.7B
$775K 0.02%
31,875
+1,180
+4% +$28.7K
VXF icon
175
Vanguard Extended Market ETF
VXF
$30.5B
$770K 0.02%
3,680
-2,113
-36% -$444K

Similar funds

Aspiriant LLC's Q4 2025 Portfolio in Review

As of Q4 2025, Aspiriant LLC held 329 positions worth $3.48B, up 6.4% from $3.27B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Aspiriant LLC deployed $149M of net new capital in Q4 2025, opening 32 new positions and adding to 177 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 102,726 shares worth $8.47M.

By sector, the portfolio is most concentrated in Technology at 4.1% of assets, up from 4% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $3.77M trimmed.

  • Aspiriant LLC's largest Q4 2025 buy was iShares Core MSCI International Developed Markets ETF: 102,726 shares worth $8.47M.
  • Aspiriant LLC added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $20M increase.
  • Aspiriant LLC's biggest Q4 2025 reduction was iShares National Muni Bond ETF, cutting an estimated $3.77M.
  • Aspiriant LLC fully exited Vanguard Total International Bond ETF in Q4 2025, selling an estimated $906K.
  • Aspiriant LLC's ten largest holdings make up 63% of its $3.48B portfolio in Q4 2025.
  • Aspiriant LLC opened 32 new positions and closed 10 in Q4 2025.
  • Aspiriant LLC's portfolio value rose 6.4% quarter-over-quarter to $3.48B.

Based on Aspiriant LLC's 13F filing for Q4 2025, filed 20 Jan 2026.